RecruitingNot ApplicableNCT05808478

Eye-tracking Technology for Severe Communication Disability

Augmentative Alternative Communication Intervention Delivered Via Eye-tracking Technology


Sponsor

IRCCS Centro Neurolesi Bonino Pulejo

Enrollment

30 participants

Start Date

Jan 22, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this project is to develop an Augmentative and Alternative Communication intervention through the use of Eye tracker system.


Eligibility

Min Age: 3 YearsMax Age: 17 Years

Inclusion Criteria5

  • aged between 3 and 17 years affected by neuropsychiatric pathology presenting complex communication needs
  • Control of eye motility and visual fixation
  • ability to maintain position in front of the monitor
  • availability of at least one member of the family nucleus to participate in the therapeutic process
  • cognitive skills appropriate to the task such as being able to recognize images and being able to memorize procedures necessary to use the various basic functions

Exclusion Criteria4

  • age not between 3 and 17 years
  • difficulty in controlling ocular motility and visual fixation
  • the unavailability of at least one member of the family nucleus to participate in the therapeutic process
  • impaired cognitive skills on the task such as being able to recognize pictures and being able to memorize procedures necessary to use various basic functions

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAAC + Eye Tracking

The AAC treatment will be supported by the use of an innovative high-tech tool, such as Eye Tracking. The duration of treatment will be 6 months, with sessions of 45 minutes twice a week.

BEHAVIORALAAC

Treatment involves the use of conventional AAC, with low-tech tools, such as PECS or sign language. The duration of treatment will be six months, twice a week, with sessions of 45 minutes.


Locations(1)

IRCCS Neurolesi Bonino Pulejo

Messina, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05808478


Related Trials